{"nctId":"NCT03045341","briefTitle":"Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment","startDateStruct":{"date":"2017-02-27","type":"ACTUAL"},"conditions":["Binge-eating Disorder","Obesity"],"count":136,"armGroups":[{"label":"BWL + NB medication","type":"EXPERIMENTAL","interventionNames":["Drug: NB medication (Naltrexone Bupropion combination)","Behavioral: Behavioral Weight Loss (BWL) counseling"]},{"label":"BWL + Placebo","type":"EXPERIMENTAL","interventionNames":["Behavioral: Behavioral Weight Loss (BWL) counseling","Other: Placebo"]},{"label":"NB medication","type":"EXPERIMENTAL","interventionNames":["Drug: NB medication (Naltrexone Bupropion combination)"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]}],"interventions":[{"name":"NB medication (Naltrexone Bupropion combination)","otherNames":["Contrave"]},{"name":"Behavioral Weight Loss (BWL) counseling","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Binge eating disorder (full criteria as described in the American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 5th edition)\n* BMI 27-30 with a controlled obesity-related co-morbidity; or BMI â‰¥ 30 and \\<50;\n* Available for the duration of the treatment and follow-up (20 months);\n* Read, comprehend, and write English at a sufficient level to complete study-related materials;\n* Able to travel to study location (New Haven, CT) for weekly visits.\n\nExclusion Criteria:\n\n* Currently taking anti-depressant medications;\n* Currently taking opioid pain medications or drugs;\n* Currently taking medications that influence eating/weight;\n* History of seizures;\n* Current substance use disorder or other severe psychiatric disturbance (e.g., suicidality);\n* Past or current anorexia nervosa, bulimia nervosa;\n* Pregnant or breastfeeding;\n* Medical status judged by study physician as contraindication.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Binge Eating Frequency (Continuous)","description":"Binge eating will be assessed by interview and self-report and the primary outcome is frequency. Frequency will be defined continuously (analyzed dimensionally).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.90","spread":"20.31"},{"groupId":"OG001","value":"7.63","spread":"9.77"},{"groupId":"OG002","value":"3.30","spread":"5.28"},{"groupId":"OG003","value":"1.97","spread":"4.87"}]}]}]},{"type":"PRIMARY","title":"Body Mass Index (Percent Weight Loss)","description":"BMI is calculated using measured height and weight. Percent weight loss, where negative values represent proportional weight loss, is calculated as the difference between weight at post-treatment and baseline weight, divided by baseline weight. By definition, all participants have 0% weight loss at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.05","spread":"4.26"},{"groupId":"OG001","value":"-2.11","spread":"5.41"},{"groupId":"OG002","value":"-4.42","spread":"5.70"},{"groupId":"OG003","value":"-5.71","spread":"5.85"}]}]}]},{"type":"SECONDARY","title":"Number of Participants Meeting Response Criteria","description":"Binge eating frequency will be assessed by interview and self-report. Frequency is defined categorically (response to treatment or non-response to treatment). Response to treatment is defined as a 65% reduction in binge eating frequency in past month, compared to baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"14","spread":null},{"groupId":"OG002","value":"20","spread":null},{"groupId":"OG003","value":"25","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":31},"commonTop":["Headache","Dry Mouth","Constipation","Nausea","Insomnia"]}}}